Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 113

    1.

    The pathology of median neuropathy in acromegaly.

    Jenkins PJ, Sohaib SA, Akker S, Phillips RR, Spillane K, Wass JA, Monson JP, Grossman AB, Besser GM, Reznek RH.

    Ann Intern Med. 2000 Aug 1;133(3):197-201.PMID: 10906834 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Clinical use of cabergoline as primary and adjunctive treatment for acromegaly.

    Moyes VJ, Metcalfe KA, Drake WM.

    Eur J Endocrinol. 2008 Nov;159(5):541-5. Epub 2008 Aug 15.PMID: 18708434 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Follow-up of pituitary tumor volume in patients with acromegaly treated with pegvisomant in clinical trials.

    Jimenez C, Burman P, Abs R, Clemmons DR, Drake WM, Hutson KR, Messig M, Thorner MO, Trainer PJ, Gagel RF.

    Eur J Endocrinol. 2008 Nov;159(5):517-23. Epub 2008 Aug 15.PMID: 18708436 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Ultrasound measurement of median and ulnar nerve cross-sectional area in acromegaly.

    Tagliafico A, Resmini E, Nizzo R, Bianchi F, Minuto F, Ferone D, Martinoli C.

    J Clin Endocrinol Metab. 2008 Mar;93(3):905-9. Epub 2007 Dec 11.PMID: 18073306 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial.

    Colao A, Pivonello R, Rosato F, Tita P, De Menis E, Barreca A, Ferrara R, Mainini F, Arosio M, Lombardi G.

    Clin Endocrinol (Oxf). 2006 Mar;64(3):342-51.PMID: 16487447 [PubMed - indexed for MEDLINE]Related articles

    6.

    Second lumbrical-interossei latency difference: A strong predictor of median neuropathy at the wrist in uremic patients.

    Sharma VK, Wilder-Smith EP.

    Neurol Neurophysiol Neurosci. 2007 Jul 16:2.PMID: 17700926 [PubMed - indexed for MEDLINE]Related articles

    7.

    Efficacy of 12-month treatment with the GH receptor antagonist pegvisomant in patients with acromegaly resistant to long-term, high-dose somatostatin analog treatment: effect on IGF-I levels, tumor mass, hypertension and glucose tolerance.

    Colao A, Pivonello R, Auriemma RS, De Martino MC, Bidlingmaier M, Briganti F, Tortora F, Burman P, Kourides IA, Strasburger CJ, Lombardi G.

    Eur J Endocrinol. 2006 Mar;154(3):467-77.PMID: 16498061 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    The relationship between symptoms and electrophysiological detected compression of the median nerve at the wrist.

    de Campos CC, Manzano GM, Leopoldino JF, Nóbrega JA, Sañudo A, de Araujo Peres C, Castelo A.

    Acta Neurol Scand. 2004 Dec;110(6):398-402.PMID: 15527453 [PubMed - indexed for MEDLINE]Related articles

    9.

    Median-radial sensory nerve comparative studies in the detection of median neuropathy at the wrist in diabetic patients.

    Imada M, Misawa S, Sawai S, Tamura N, Kanai K, Sakurai K, Sakamoto S, Nomura F, Hattori T, Kuwabara S.

    Clin Neurophysiol. 2007 Jun;118(6):1405-9. Epub 2007 Apr 23.PMID: 17452013 [PubMed - indexed for MEDLINE]Related articles

    10.

    Quantitative MRI of the wrist and nerve conduction studies in patients with idiopathic carpal tunnel syndrome.

    Uchiyama S, Itsubo T, Yasutomi T, Nakagawa H, Kamimura M, Kato H.

    J Neurol Neurosurg Psychiatry. 2005 Aug;76(8):1103-8.PMID: 16024888 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Effect of occupational keyboard typing on magnetic resonance imaging of the median nerve in subjects with and without symptoms of carpal tunnel syndrome.

    Shafer-Crane GA, Meyer RA, Schlinger MC, Bennett DL, Robinson KK, Rechtien JJ.

    Am J Phys Med Rehabil. 2005 Apr;84(4):258-66.PMID: 15785258 [PubMed - indexed for MEDLINE]Related articles

    12.

    Improvement of acromegaly after octreotide LAR treatment.

    Mangupli R, Lisette A, Ivett C, Paul C, de los Ríos Victoria C, Luis CJ.

    Pituitary. 2003;6(1):29-34.PMID: 14674721 [PubMed - indexed for MEDLINE]Related articles

    13.

    Glucose homeostasis and safety in patients with acromegaly converted from long-acting octreotide to pegvisomant.

    Barkan AL, Burman P, Clemmons DR, Drake WM, Gagel RF, Harris PE, Trainer PJ, van der Lely AJ, Vance ML.

    J Clin Endocrinol Metab. 2005 Oct;90(10):5684-91. Epub 2005 Aug 2.PMID: 16076947 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly.

    Bourdelot A, Coste J, Hazebroucq V, Gaillard S, Cazabat L, Bertagna X, Bertherat J.

    Eur J Endocrinol. 2004 Jun;150(6):763-71.PMID: 15191345 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Skin morphological changes in growth hormone deficiency and acromegaly.

    Lange M, Thulesen J, Feldt-Rasmussen U, Skakkebaek NE, Vahl N, Jørgensen JO, Christiansen JS, Poulsen SS, Sneppen SB, Juul A.

    Eur J Endocrinol. 2001 Aug;145(2):147-53.PMID: 11454509 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Effects of prolonged wrist flexion on transmission of sensory information in carpal tunnel syndrome.

    Sesek RF, Khalighi M, Bloswick DS, Anderson M, Tuckett RP.

    J Pain. 2007 Feb;8(2):137-51. Epub 2006 Sep 1.PMID: 16949877 [PubMed - indexed for MEDLINE]Related articles

    17.

    Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution.

    Jallad RS, Musolino NR, Salgado LR, Bronstein MD.

    Clin Endocrinol (Oxf). 2005 Aug;63(2):168-75.PMID: 16060910 [PubMed - indexed for MEDLINE]Related articles

    18.

    Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size.

    Bevan JS, Atkin SL, Atkinson AB, Bouloux PM, Hanna F, Harris PE, James RA, McConnell M, Roberts GA, Scanlon MF, Stewart PM, Teasdale E, Turner HE, Wass JA, Wardlaw JM.

    J Clin Endocrinol Metab. 2002 Oct;87(10):4554-63.PMID: 12364434 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Effect of gender and gonadal status on the long-term response to somatostatin analogue treatment in acromegaly.

    Colao A, Pivonello R, Cappabianca P, Briganti F, Tortora F, Auriemma RS, De Martino MC, Marzullo P, Lombardi G.

    Clin Endocrinol (Oxf). 2005 Sep;63(3):342-9.PMID: 16117824 [PubMed - indexed for MEDLINE]Related articles

    20.

    [Decrease in serum ghrelin levels in patients with acromegaly normalize after successful surgical treatment]

    Kozakowski J, Rabijewski M, Zgliczyński W.

    Endokrynol Pol. 2005 Nov-Dec;56(6):862-70. Polish. PMID: 16821203 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data